Clinical and economic impact of first-line or drug-naïve catheter ablation and delayed second-line catheter ablation for atrial fibrillation using a patient-level simulation model-Reference-Cited by-同舟云学术

Clinical and economic impact of first-line or drug-naïve catheter ablation and delayed second-line catheter ablation for atrial fibrillation using a patient-level simulation model

Published:2024-09-10 Issue: Volume: Page:1-17
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Arbelo Elena¹²³⁴^ORCID,Ponti Roberto De⁵^ORCID,Cohen Lucas⁶^ORCID,Pastor Laura⁶,Costa Graca⁷^ORCID,Hempel Marike⁸^ORCID,Grima Daniel⁶

Affiliation:

1. Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona. Barcelona (Spain)

2. IDIBAPS, Institut d’Investigació August Pi i Sunyer (IDIBAPS). Barcelona (Spain)

3. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid (Spain)

4. European Reference Network for rare, low prevalence and complex diseases of the heart - ERN GUARD-Heart

5. Department of Medicine and Surgery, University of Insubria, Varese, Italy

6. EVERSANA, Burlington, ON, Canada

7. Biosense Webster, Porto, Portugal

8. Johnson & Johnson Medical Switzerland, Zug, Switzerland

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2399438

Reference68 articles.

1. Hindricks G Potpara T Dagres N et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2020.

2. Zoni-Berisso M Lercari F Carazza T et al. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology. 2014;6:213.

3. Menke J Lüthje L Kastrup A et al. Thromboembolism in atrial fibrillation. The American journal of cardiology. 2010;105(4):502-510.

4. Nyong J Amit G Adler AJ et al. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation. Cochrane Database Syst Rev. 2016 Nov 22;11(11):Cd012088.

5. Tzeis S Gerstenfeld EP Kalman J et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. EP Europace. 2024;26(4):euae043.